-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cidara Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
- Cidara Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$17.4M, a 289% decline year-over-year.
- Cidara Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$140M, a 539% decline year-over-year.
- Cidara Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$24.5M, a 26.9% increase from 2022.
- Cidara Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$33.5M, a 20.7% increase from 2021.
- Cidara Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$42.3M, a 41.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)